HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Communication critical in management of patients with ocular cancer
-
- Part II: Expert witness 101, finding and taking the case Jeffrey R. Wahl, JD
- FDA approved test that determines risk of breast cancer recurrence
- Tamoxifen, exemestane sequence improved survival
- Bevacizumab with FOLFOX4 improved survival, but not response in colorectal cancer
- Dasatinib may be effective option for pediatric leukemia
- Presence of bleeding disorders in premenopausal women a rising concern
- Recognize and treat von Willebrand’s disease
- Aspirin saved lives of patients with cancer who had myocardial infarction
-
- Adjuvant trastuzumab in breast cancer: more questions than answers? Chad M. Barnett, PharmD, BCOP; Laura Boehnke Michaud, PharmD